<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04749212</url>
  </required_header>
  <id_info>
    <org_study_id>621/2020</org_study_id>
    <nct_id>NCT04749212</nct_id>
  </id_info>
  <brief_title>Perioperative Troponin I and NT Pro-BNP in Lung Resection</brief_title>
  <official_title>Incidence and Clinical Relevance of Perioperative Elevation of Troponin I and N- Terminal Pro-Brain Natriuretic Peptide in Patients Undergoing Lung Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      After lung resection, troponin elevation may be regulated by mechanisms other than myocardial&#xD;
      ischemia. Perioperative natriuretic peptides measurement may help identify changes in&#xD;
      ventricular function during thoracic surgery. Integrating both cardiac biomarkers may improve&#xD;
      the predictive value for cardiovascular complications after lung resection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives: To evaluate the incidence and magnitude of perioperative N-terminal pro brain&#xD;
      natriuretic peptide (NT-proBNP) and high-sensitivity troponin I (Tn I) elevation in patients&#xD;
      undergoing pulmonary resection and its predictive value for cardiovascular complications.&#xD;
      Methodology: Prospective, multicenter, observational cohort study in patients &gt;45 years&#xD;
      undergoing elective thoracic surgery for lung resection. Cardiac biomarkers Tn I and&#xD;
      NT-proBNP will be measured preoperatively and at postoperative days 1 and 2. Risk score for&#xD;
      major cardiovascular postoperative complications will be calculated depending of both&#xD;
      biomarkers perioperative changes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>NT-proBNP perioperative changes</measure>
    <time_frame>Change from baseline NT-proBNP at two-days after surgery</time_frame>
    <description>Perioperative change in NT-Pro-Brain Natriuretic Peptide (NT-proBNP) levels in patients undergoing pulmonary resection. Cutt-of values will be NT-proBNP ≥ 300 pg/ml pg/ml</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TnI perioperative changes</measure>
    <time_frame>Change from baseline TnI at two-days after surgery</time_frame>
    <description>Perioperative changes in high-sensitivity troponin I (TnI) levels in patients undergoing pulmonary resection. Cutt-of values will be TnI ≥45 ng/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major cardiovascular complications</measure>
    <time_frame>30-days after surgery</time_frame>
    <description>Postoperative non-fatal cardiac arrest, acute myocardial infarction, angina, congestive heart failure, new clinically relevant cardiac arrhythmia, cardiovascular death</description>
  </primary_outcome>
  <enrollment type="Anticipated">345</enrollment>
  <condition>Cardiac Ischemia</condition>
  <condition>Thoracic Cancer</condition>
  <condition>Complication,Postoperative</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>serum high-sensitivity Troponin I (TnI) and NT-Pro-Brain Natriuretic Peptide (NT-proBNP)</intervention_name>
    <description>Both biomarkers will be determined in each patient preoperatively and at postoperative day 1 and day 2.Measurements will not necessarily be taken independently of other measurements, meaning that the addition of the biomarker could be included in routine pre or postoperative day-1 and day 2 blood tests.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adulty patients undergoing elective thoracic and lung resection surgery: neumonectomy,&#xD;
        lobectomy, bilobectomy or segmentectomy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥45 years old&#xD;
&#xD;
          -  Patients undergoing elective surgery for lung resection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing urgent, emergent, or nonthoracic surgery&#xD;
&#xD;
          -  Patients or family did not consent to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 18, 2021</study_first_submitted>
  <study_first_submitted_qc>February 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2021</study_first_posted>
  <last_update_submitted>February 9, 2021</last_update_submitted>
  <last_update_submitted_qc>February 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Natriuretic Peptide, Brain</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

